Brief: Noxopharm Posts HY Loss After Income Tax Expense Attributable A$5.4 Million
24/02/2023 03:59
Feb 24 (Reuters) - Noxopharm Ltd NOX.AX :
* HY LOSS AFTER INCOME TAX EXPENSE ATTRIBUTABLE A$5.4
MILLION
VERSUS LOSS OF A$8.6 MILLION
Source text for Eikon: ID:nASX5PSp5J
Further company coverage: NOX.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer